Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (250 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 May 2024 – 20 Aug 2026, limited by Bandhan Innovation Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Bandhan Innovation Fund | Nifty 500 |
|---|---|---|
| 02 May 2024 | ₹100.00 | ₹100.00 |
| 11 Jul 2024 | ₹114.19 | ₹109.11 |
| 19 Sep 2024 | ₹125.63 | ₹113.14 |
| 28 Nov 2024 | ₹125.09 | ₹106.79 |
| 06 Feb 2025 | ₹120.55 | ₹102.79 |
| 17 Apr 2025 | ₹116.76 | ₹102.84 |
| 26 Jun 2025 | ₹128.08 | ₹111.54 |
| 04 Sep 2025 | ₹132.30 | ₹108.23 |
| 13 Nov 2025 | ₹137.12 | ₹112.96 |
| 22 Jan 2026 | ₹128.78 | ₹109.13 |
| 02 Apr 2026 | ₹114.34 | ₹99.31 |
| 11 Jun 2026 | ₹128.44 | ₹104.89 |
| 20 Aug 2026 | ₹151.02 | ₹111.52 |
| Metric | Bandhan · Direct · IDCW NAV ₹15.20 Very High risk ★★★★☆ 1Y | Category median Sectoral/ Thematic · 250 funds |
|---|---|---|
| +13.99% | +5.11% | |
| — | +13.02% | |
| — | +11.14% | |
| — | +12.26% | |
| +19.63% | +11.82% | |
| +17.43% | — | |
| — | +14.62% | |
| — | +12.95% | |
| — | +13.24% | |
| Risk | ||
| 17.31% | 15.88% | |
| 0.43 | 0.35 | |
| 0.59 | 0.47 | |
| -19.69% | -25.18% | |
| Nifty 500 | — | |
| — | +1.40% | |
| — | 0.98 | |
| — | 101.5% | |
| — | 97.0% | |
| 0.85% | 1.14% | |
| ₹2,151Cr | ₹1,162Cr | |
| Up to 0.50% | — | |
| None | — | |
| ₹100 | — | |
| ₹1.00K | — | |
| 83% | 45% | |
| Brijesh Shah | — | |
| 02 May 2024 | — | |
| 80 | — | |
| 31.8% | — | |
| 1.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.